Advent Technologies (ADN) Reports Q2 Loss of $0.41

Advent Technologies (NASDAQ: ADN) reported Q2 EPS of ($0.41). Revenue for the quarter came in at $1.1 million.

For earnings history and earnings-related data on Advent Technologies (ADN) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c